These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4155406)

  • 1. Naloxone and the narcotic abuser: a controlled study of partial blockade.
    Kurland AA; Hanlon TE; McCabe OL
    Int J Addict; 1974; 9(5):663-72. PubMed ID: 4155406
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone and the narcotic abuser: a low-dose maintenance program.
    Kurland AA; Henderson JM; Krantz JC; Kerman F
    Int J Addict; 1973; 8(1):127-41. PubMed ID: 4351589
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of pentazocine dependence in hospitalized patients after naloxone administration.
    Sandoval RG; Wang RI
    Psychopharmacologia; 1973 Jun; 30(3):205-15. PubMed ID: 4577443
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report.
    Kurland AA; McCabe L
    J Clin Pharmacol; 1976 Jan; 16(1):66-74. PubMed ID: 1107361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingent naloxone treatment of the narcotic addict: a pilot study.
    Kurland AA; McCabe L; Hanlon T
    Int J Addict; 1976; 11(1):131-42. PubMed ID: 1254364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMPI changes in briefly hospitalized non-narcotic drug users.
    Graf K; Baer PE; Comstock BS
    J Nerv Ment Dis; 1977 Aug; 165(2):126-33. PubMed ID: 18551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Naloxone.
    Lancet; 1975 Mar; 1(7909):734. PubMed ID: 47492
    [No Abstract]   [Full Text] [Related]  

  • 9. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingent naloxone (N-allylnoroxymorphone) treatment of the paroled narcotic addict.
    Kurland AA; McCabe L; Hanlon TE
    Int Pharmacopsychiatry; 1975; 10(3):157-68. PubMed ID: 1099047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An MMPI discriminant function to distinguish alcoholics from narcotic addicts: effects of age, sex and psychopathology.
    McLachlan JF
    J Clin Psychol; 1975 Jan; 31(1):163-5. PubMed ID: 234476
    [No Abstract]   [Full Text] [Related]  

  • 12. MMPI identification of nonrehabilitants among disabled veterans.
    Campbell HG; Clarkson QD
    J Pers Assess; 1977 Jun; 41(3):266-9. PubMed ID: 142142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality attributes of the young, nonaddicted drug abuser.
    Heller ME; Mordkoff AM
    Int J Addict; 1972; 7(1):65-72. PubMed ID: 4402934
    [No Abstract]   [Full Text] [Related]  

  • 14. THE HOSPITALIZED NARCOTIC ADDICT.
    GORWITZ K
    Md State Med J; 1965 Aug; 14():143. PubMed ID: 14341799
    [No Abstract]   [Full Text] [Related]  

  • 15. Naloxone and opiate addiction.
    Brewer C; Mathew KI
    Lancet; 1989 Sep; 2(8664):683-4. PubMed ID: 2570938
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of drug overdosage with naloxone, a specific narcotic antagonist.
    Evans LE; Swainson CP; Roscoe P; Prescott LF
    Lancet; 1973 Mar; 1(7801):452-5. PubMed ID: 4120366
    [No Abstract]   [Full Text] [Related]  

  • 17. Narcotic antagonist treatment of addict parolees--the failure of an effective approach.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Compr Psychiatry; 1977; 18(3):211-9. PubMed ID: 858238
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism and pharmacokinetics of naloxone.
    Weinstein SH; Pfeffer M; Schor JM
    Adv Biochem Psychopharmacol; 1973; 8(0):525-35. PubMed ID: 4794980
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of client ethnicity on clinical interpretation of the MMPI-2.
    Knaster CA; Micucci JA
    Assessment; 2013 Feb; 20(1):43-7. PubMed ID: 23118266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride.
    Kurland AA; McCabe OL; Hanlon TE; Sullivan D
    Am J Psychiatry; 1977 Dec; 134(12):1408-10. PubMed ID: 335903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.